M
Mark E. Cooper
Researcher at University of Queensland
Publications - 1514
Citations - 141899
Mark E. Cooper is an academic researcher from University of Queensland. The author has contributed to research in topics: Diabetes mellitus & Diabetic nephropathy. The author has an hindex of 158, co-authored 1463 publications receiving 124887 citations. Previous affiliations of Mark E. Cooper include University of Cambridge & University of Adelaide.
Papers
More filters
Journal ArticleDOI
Role of hyperlipidemia in progressive renal disease: focus on diabetic nephropathy
Karin Jandeleit-Dahm,Zemin Cao,Alison J. Cox,Darren J. Kelly,Richard E. Gilbert,Mark E. Cooper +5 more
TL;DR: Atorvastatin therapy was associated with a modest reduction in proteinuria and glomerulosclerosis without influencing lipid levels or renal function in STNx rats, and appears to confer renoprotection via effects on prosclerotic cytokines such as TGF-beta and macrophage accumulation, independent of their lipid-lowering properties.
Journal ArticleDOI
Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
Vlado Perkovic,Vlado Perkovic,Rajiv Agarwal,Paola Fioretto,Brenda R. Hemmelgarn,Adeera Levin,Merlin C. Thomas,Merlin C. Thomas,Christoph Wanner,Bertram L. Kasiske,David C. Wheeler,Per-Henrik Groop,Per-Henrik Groop,George L. Bakris,Mark E. Cooper,Dong Wan Chae,Michael H. Davidson,Ian H. de Boer,Dick de Zeeuw,Alessia Fornoni,Luigi Gnudi,Charles A. Herzog,Adriana M. Hung,Tazeen H. Jafar,Meg Jardine,Vivekanand Jha,Linong Ji,Steven E. Kahn,Robyn G Langham,Edgar V. Lerma,Ronald C.W. Ma,Hirofumi Makino,Michel Marre,Michael Mauer,Kaj Metsärinne,Robert G. Nelson,Roberto Pecoits-Filho,Carol A. Pollock,Mohan Rajapurkar,Peter Rossing,Ivan Rychlik,Kumar Sharma,Robert Stanton,Vladimír Tesař,Ilkka Tikkanen,Charles R.V. Tomson,Robert D. Toto,Yusuke Tsukamoto,Katherine R. Tuttle,Takashi Wada,Winfred W. Williams,Hong Zhang,Sophia Zoungas +52 more
TL;DR: The current state of knowledge regarding optimal glycemic control, current antidiabetic agents and their safety, and new therapies being developed to improve kidney function and cardiovascular outcomes for this vulnerable population of people with diabetes are assessed.
Journal ArticleDOI
Transpiration Response of Maize Hybrids to Atmospheric Vapour Pressure Deficit
TL;DR: Transpiration rate was examined of 35 single-cross hybrids to determine whether hybrids can be identified that express limited transpiration under high vapour pressure deficit (VPD) conditions, indicating that expression of the trait was consistent.
Journal ArticleDOI
Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria.
Josephine M. Forbes,Fabrice Bonnet,Leileata M. Russo,Wendy C. Burns,Zemin Cao,Riccardo Candido,Hiroshi Kawachi,Terri J. Allen,Mark E. Cooper,George Jerums,Tanya M. Osicka +10 more
TL;DR: Reduction in renal nephrin gene and protein expression is closely associated with the development of albuminuria, as observed in an experimental model of diabetes and hypertension.
Journal ArticleDOI
Osteopontin expression in progressive renal injury in remnant kidney: Role of angiotensin II
Xue Q. Yu,Leonard L. Wu,Xiao R. Huang,Niansheng Yang,Richard E. Gilbert,Mark E. Cooper,Richard J. Johnson,Kar N. Lai,Hui Y. Lan +8 more
TL;DR: An up-regulation of OPN expression may play a role in progressive renal injury following subtotal nephrectomy in rats and may be one of the mechanisms by which Ang II blockade attenuated renal injury after renal ablation.